Ypsomed
Manuel Stucki has been serving as the Quality Assurance Manager for Autoinjectors at Ypsomed AG since November 2016, where responsibilities include managing the YpsoMate® Autoinjektor platform and overseeing quality-related topics, including deviation reports (CAPA), investigations, change management, production approvals, and quality documentation. Prior to this role, Manuel Stucki worked as a Quality Engineer and Engineer in Industrialisation & Optimisation, focusing on process improvement, validation, and ensuring compliance with relevant regulations. Previous experience includes various positions in automation and control system design at Marti Technik AG, BLS AG, Lescom AG, and Scheidegger Fernsteuerungen AG from 2009 to 2016. Manuel Stucki holds a Bachelor of Applied Science in Micro and Medical Technology from Berner Fachhochschule BFH and has a Lean Six Sigma Green Belt certification.
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.